Skip to content

Application of Seddinger technique in midline catheterization in fluid therapy of patients with acute poisoning

Application of Seddinger technique in midline catheterization in fluid therapy of patients with acute poisoning

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000029441
Enrollment
Unknown
Registered
2020-02-02
Start date
2020-02-15
Completion date
Unknown
Last updated
2020-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute poisoning

Interventions

Case series:application of Seddinger technique in midline catheterization in fluid therapy

Sponsors

Qilu Hospital of Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) patients aged between 18 and 80 years; (2) estimated time of intravenous infusion >=2 weeks; (3) patients receiving midline catheterization for the first time; (4) agree to conduct midline catheter catheterization, signed informed consent.

Exclusion criteria

Exclusion criteria: (1) there is infection or injury at the puncture site; (2) the catheterization site has a history of radiotherapy or vascular surgery; (3) superior vena cava compression syndrome; (4) affected limbs receiving radical mastectomy for breast cancer and axillary lymph node dissection; (5) unconscious, restless patients; (6) The drugs used were continuously corrosive drugs, parenteral nutrition, rehydration with osmotic pressure in excess of 900 mOsm/L.

Design outcomes

Primary

MeasureTime frame
Data of catheterization (arm circumference, depth of catheterization, amount of bleeding during catheterization, whether there is blood leakage at the puncture point, pipeline maintenance, etc.);Rate of blockage of the pipeline, incidence of phlebitis and thrombosis after catheterization;

Contacts

Public ContactJian Xiangdong

Qilu Hospital of Shandong University

jianxiangdongvip@163.com+86 18560083182

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026